Skip to content

Comparison of the efficacy of dexmedetomidine with propofol on agitation and pain during dressing in burn patients undergoing sedation with ketamine

Comparison of the efficacy of dexmedetomidine with propofol on agitation and pain during dressing in burn patients undergoing sedation with ketamine, a double blinded randomized clinical trial.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20141001019359N19
Enrollment
90
Registered
2025-12-02
Start date
2025-12-06
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and sedation during burn dressing changes. Acute pain, not elsewhere classified

Interventions

Intervention 1: Intervention group:Patients in this group will receive ketamine at a sedative dose of 1 mg/kg intravenously over a period of 4 minutes Before intervention. Intervention 2: Intervention

Sponsors

Bojnourd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Participants with no known hypersensitivity to the intervention drugs. ASA physical status I-II No history of drug addiction

Exclusion criteria

Exclusion criteria: Participants with a history of severe cardiac, renal, psychiatric, or systemic disease

Design outcomes

Primary

MeasureTime frame
Pain assessment during burn dressing change. Timepoint: during burn dressing change. Method of measurement: Visual Analog Score (VAS).;Assessment of sedation during burn dressing changes. Timepoint: during burn dressing change. Method of measurement: Richmond Agitation Sedation Scale (RASS) Scale.

Secondary

MeasureTime frame
Evaluation of hemodynamic variables. Timepoint: During changing a burn dressing. Method of measurement: Researcher-made questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Zeraati

Bojnourd University of Medical Sciences

zeraatih@gmail.com+98 58 3151 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026